Gustavo Guimarães Moreira Balbi (Gustavo Gm Balbi, G G M Balbi, Gustavo G M Balbi)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 10

Top Topics

Transcranial Magnetic Stimulation

Systemic Lupus Erythematosus

Disease Activity

Top Venues

Advances in rheumatology (London, England)

Revista da Associacao Medica Brasileira (1992)

This page only lists publications with an associated author ORCID identifier.

Publications

Adriana M de M Franco, Lana S Makita, Virginia C Perrut, Gustavo Guimarães Moreira Balbi, Alexandre M Barros, Flavio M C Medina, Flavio Signorelli
Ocular involvement in primary antiphospholipid syndrome: results of an extensive ophthalmological evaluation performed in the APS-Rio cohort. Lupus (2022)
Maria Ester S Fonseca, Gustavo Guimarães Moreira Balbi, Flavio Signorelli, Christiane P Gouvea, Danieli Castro de Oliveira Andrade
CoaguChek® XS versus standard laboratory prothrombin time for anticoagulant monitoring in patients with antiphospholipid syndrome. Lupus 31 (5) (2022)
Taurino Dos Santos Rodrigues Neto, Epitacio Ds Neto, Gustavo Guimarães Moreira Balbi, Flavio Signorelli, Alex H Higashi, Mário Luiz R Monteiro, Eloisa S Bonfa, Leandro C Zacharias, Danieli Castro de Oliveira Andrade
Ocular findings in asymptomatic patients with primary antiphospholipid syndrome. Lupus 31 (14) (2022)
Flavio Signorelli, Gustavo Guimarães Moreira Balbi, Nádia Emi Aikawa, Clovis Artur Almeida da Silva, Léonard de Vinci Kanda Kupa, Ana C Medeiros-Ribeiro, Emily Fn Yuki, Sandra Gofinet Pasoto, Carla Gs Saad, Eduardo Ferreira Borba, Luciana Parente Costa Seguro, Tatiana Pedrosa, Vitor Antonio de Angeli Oliveira, Ana Luisa Cerqueira de Sant'Ana Costa, Carolina T Ribeiro, Roseli Eliana Beseggio Santos, Danieli Castro de Oliveira Andrade, Eloisa S Bonfa
Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome. Lupus 31 (8) (2022)
Carla Baleeiro, Camila Sc Duran, Flavio Signorelli, Gustavo Guimarães Moreira Balbi, Eloisa S Bonfa, Danieli Co Andrade
Distinct features of youth-onset primary antiphospholipid syndrome. Lupus 30 (12) (2021)
Flavio Signorelli, Gustavo Guimarães Moreira Balbi, Eloisa S Bonfa, Eduardo F Borba, Danieli Castro de Oliveira Andrade
Avoiding misclassification of thrombotic primary antiphospholipid syndrome as systemic lupus erythematosus (SLE): What are the best-performing SLE classification criteria? Lupus 30 (11) (2021)
E Cunha, Vivian Regina Guzela, Gustavo Guimarães Moreira Balbi, Carlos Walter Sobrado Junior, Danieli Castro de Oliveira Andrade
Anorectal diseases in patients with Antiphospholipid syndrome: a cross-sectional study. Advances in rheumatology (London, England) 60 (1) (2020)
Andreas Funke, Henrique Luiz Staub, Odirlei Andre André Monticielo, Gustavo Guimarães Moreira Balbi, Adriana Danowski, Mittermayer Barreto Santiago, Danieli Castro de Oliveira Andrade, Jozelia Rêgo
Non-criteria Antiphospholipid Antibodies: a narrative review. Revista da Associacao Medica Brasileira (1992) 66 (11) (2020)
Gustavo Guimarães Moreira Balbi, Marcelo de Souza Pacheco, Odirlei Andre Monticielo, Andreas Funke, Adriana Danowski, Mittermayer Barreto Santiago, Henrique Luiz Staub, Jozelia Rêgo, Danieli Castro Oliveira de Andrade
Antiphospholipid Syndrome Committee of the Brazilian Society of Rheumatology position statement on the use of direct oral anticoagulants (DOACs) in antiphospholipid syndrome (APS). Advances in rheumatology (London, England) 60 (1) (2020)
Adriana M de M Franco, Flavio Mac Cord Medina, Gustavo Guimarães Moreira Balbi, Roger Abramino Levy, Flavio Signorelli
Ophthalmologic manifestations in primary antiphospholipid syndrome patients: A cross-sectional analysis of a primary antiphospholipid syndrome cohort (APS-Rio) and systematic review of the literature. Lupus 29 (12) (2020)